Abstract
Weight loss is frequently seen in patients with advanced cancer and has long been recognised to be associated with decreased survival [1]. Cancer cachexia is a complex syndrome depending on cytokines, eicosanoids, and classical hormones, and characterised by progressive weight loss with depletion of host reserves of skeletal muscle and adipose tissue. It is the net result of profound metabolic changes that appear in patients with advanced stages of cancer, and is characterised by net breakdown of skeletal muscle and alterations in fat and carbohydrate metabolism. Cachexia is the most common paraneoplastic syndrome, and is also referred to as the cancer anorexia-cachexia syndrome, with features of anorexia, early satiety, weakness, and fatigue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dewys WD, Begg C, Lavin PT et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69:491–497
Bosaeus I, Daneryd P, Svanberg E et al (2001) Dietary intake and resting energy expenditure in relation to weight loss in cancer patients. Int J Cancer 93:380–383
Baracos VE (2002) Hypercatabolism and hypermetabolism in wasting states. Curr Opin Clin Nutr Metab Care 5:237–239
Cohn SH, Gartenhaus W. Vartsky D et al (1981) Body composition and dietary intake in neoplastic disease. Am J Clin Nutr 34:1997–2004
Parkinson SA, Lewis J, Morris R et al (1987) Oral protein and energy supplements in cancer patients. Hum Nutr Appl Nutr 41:233–243
Simons JP, Schols AM, Hoefnagels JM et al (1998) Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial. Cancer 82:553–560
Staalvan den Brekel AJ, Schols AM, ten Velde GP et al (1994) Analysis of the energy balance in lung cancer patients. Cancer Res 54:6430–6433
Wigmore SJ, Plester CE, Ross JA et al (1997) Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg 84:196–197
Levine JA, Morgan MY (1998) Preservation of macronutrient preferences in cancer anorexia. Br J Cancer 78:579–581
Fordy C, Glover C, Henderson DC et al (1999) Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver métastases. Br J Surg 86:639–644
Lundholm K, Edstrom S, Karlberg I et al (1982) Glucose turnover, gluconeogenesis from glycerol,and estimation of net glucose cycling in cancer patients. Cancer 50:1142–1150
Warnold I, Lundholm K, Schersten T (1978) Energy balance and body composition in cancer patients. Cancer Res 38:1801–1807
Bozzetti F, Pagnoni AM, Del Vecchio M (1980) Excessive caloric expenditure as a cause of malnutrition in patients with cancer. Surg Gynecol Obstet 150:229–234
Hyltander A, Drott C, Korner U et al (1991) Elevated energy expenditure in cancer patients with solid tumours. Eur J Cancer 27:9–15
Dempsey DT, Feurer ID, Knox LS et al (1984) Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 53:1265–1273
Knox LS, Crosby LO, Feurer IDetal (1983) Energyexpenditure in malnourished cancer patients. Ann Surg 197:152–162
Barber MD, Ross JA, Fearon KC (1999) Cancer cachexia. Surg Oncol 8:133–141
Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2:862–871
Zylicz Z, Schwantje O, Wagener DJ et al (1990) Metabolic response to enterai food in different phases of cancer cachexia in rats. Oncology 47:87–91
Jatoi A, Daly BD, Hughes V et al (1999) The prognostic effect of increased resting energy expenditure prior to treatment for lung cancer. Lung Cancer 23:153–158
Hyltander A, Korner U, Lundholm KG (1993) Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours. Eur J Clin Invest 23:46–52
Drott C, Svaninger G, Lundholm K (1988) Increased urinary excretion of cortisol and catecholamines in malnourished cancer patients. Ann Surg 208:645–650
Drott C, Persson H, Lundholm K (1989) Cardiovascular and metabolic response to adrenaline infusion in weightlosing patients with and without cancer. Clin Physiol 9:427–439
Lundholm K, Daneryd P, Korner U et al (2004) Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 24:505–512
Lindmark L, Bennegard K, Eden E et al (1986) Thermic effect and substrate oxidation in response to intravenous nutrition in cancer patients who lose weight. Ann Surg 204:628–636
Moses AW, Slater C, Preston T et al (2004) Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90:996–1002
Jatoi A, Hillman S, Stella PJ et al (2003) Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patients. Support Care Cancer 11:460–464
Gibney E, Elia M, Jebb SA et al (1997) Total energy expenditure in patients with small-cell lung cancer: results of a validated study using the bicarbonate-urea method. Metabolism 46:1412–1417
Anonymous (1989) Parenteral nutrition in patients receiving cancer chemotherapy. American College of Physicians. Ann Intern Med 110:734–736
Bruera E, Macmillan K, Kuehn N et al (1990) A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 66:1279–1282
Lundholm K, Gelin J, Hyltander A et al (1994) Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 54:5602–5606
Lundholm K, Daneryd P, Bosaeus I et al (2004) Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism and function. A randomized prospective study. Cancer 100:1967–1977
Fearon KC, Von Meyenfeldt MF, Moses AG et al (2003) Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52:1479–1486
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Lundholm, K., Bosaeus, I. (2006). Dietary Intake, Resting Energy Expenditure, Weight Loss, and Survival in Cancer Patients. In: Mantovani, G., et al. Cachexia and Wasting: A Modern Approach. Springer, Milano. https://doi.org/10.1007/978-88-470-0552-5_47
Download citation
DOI: https://doi.org/10.1007/978-88-470-0552-5_47
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0471-9
Online ISBN: 978-88-470-0552-5
eBook Packages: MedicineMedicine (R0)